PreveCeutical Medical Inc. announced that it has entered into a series of unsecured, non-convertible and interest-free loan agreements with, the Company's Chief Executive Officer, interim Chief Financial Officer and Chair, Stephen Van Deventer, and the Company's former President and director, Kimberly Van Deventer (collectively, the "Lenders"), in the aggregate amount of $297,731.00 (the "Loans"). The proceeds of the Loans are intended to be used for working capital purposes.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 CAD | 0.00% |
|
0.00% | -20.00% |
1st Jan change | Capi. | |
---|---|---|
-20.00% | 7.9M | |
+63.05% | 856B | |
+39.64% | 631B | |
-4.78% | 359B | |
+17.52% | 325B | |
+8.43% | 297B | |
+5.56% | 234B | |
+16.50% | 226B | |
+14.63% | 177B | |
+1.08% | 165B |
- Stock Market
- Equities
- PREV Stock
- News PreveCeutical Medical Inc.
- PreveCeutical Medical Inc. Enters into Series of Unsecured, Non-Convertible and Interest-Free Loan Agreements